Key facts
- It has raised $7.9M; the latest was Later Stage VC ($7.1M) in Nov 2025.
- Notable investors include YSpace (Toronto), Michele Romanow, Canadian Imperial Bank of Commerce, Femtech Canada, Pender Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Science & Humans
- ·The full record, as it builds
Funding rounds
No funding rounds for Science & Humans are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Science & Humans
Operator of a hormone health platform intended to support diagnostic evaluation and treatment of hormone-related conditions. The company provides access to medical professionals who offer hormone therapy, personalized treatment programs, laboratory assessments, and online care for concerns related to menopause, andropause, weight management, hair loss, and sexual health, enabling patients to manage hormone imbalances and receive ongoing medical guidance from home.
- Sector
- Healthcare
- HQ
- Mississauga, Canada
- Founded
- 2018
- Employees
- 77
- Website
- scienceandhumans.com/
- Ownership
- Privately Held (backing)
Science & Humans doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Science & Humans shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Science & Humans in its N-PORT filings yet. We sweep new filings monthly.